Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Ottawa

$83,035.00

Proteomic Technologies for Complex Samples

EF 2016-17

Résumé
Proteins play essential roles in biological processes. These roles are reflected through changes in levels, interactions, localization and post-translational modifications of proteins. Therefore, the ability to identify and monitor the level of proteins in the cell and the changes in their modifications can greatly help our understanding of biological processes. Technologies are being developed to study the proteome (ensembles of proteins). Unfortunately, these technologies are not able to look at all the proteins. This leads to under-representation of important subgroups of proteins in proteomic studies. In particular, plasma membrane proteins which are important for drug discovery, cell signaling, and other biological processes are often under-represented using current proteomic technologies. More importantly, even when they are observed by global proteomic technologies, the information about the changes in protein levels and modifications that are specific to the membrane can be overshadowed. We propose to develop microfluidic technologies that will allow the study of sub-proteomes based on cellular compartments with an initial focus on plasma membrane proteins. Our short term objectives (1-3 years) are to develop new membrane solubilization protocols and an ensemble of microfluidic technologies for processing, identifying and relative quantitating membrane proteomes by mass spectrometry. An important aspect of our objectives is to provide training for students, postdoctoral fellows, and visiting scientists on the development of microfluidic proteomic technologies and mass spectrometry. Our medium term objectives (3-5 years) are to integrate these technologies into single devices to demonstrate their compatibility for analyzing sub-proteomes. Our long term objective is to apply these microfluidic technologies to study the dynamicity of the membrane proteome, to automate these systems, and to explore their commercialization.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
217066-2013
Name nom
Figeys, Daniel
Department département
Biochemistry, Microbiology and Immunology
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2013
Award amount
83035
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
4
Nb partie
5
Application title
Proteomic Technologies for Complex Samples
Keyword
NSERC
Application summary
Proteins play essential roles in biological processes. These roles are reflected through changes in levels, interactions, localization and post-translational modifications of proteins. Therefore, the ability to identify and monitor the level of proteins in the cell and the changes in their modifications can greatly help our understanding of biological processes. Technologies are being developed to study the proteome (ensembles of proteins). Unfortunately, these technologies are not able to look at all the proteins. This leads to under-representation of important subgroups of proteins in proteomic studies. In particular, plasma membrane proteins which are important for drug discovery, cell signaling, and other biological processes are often under-represented using current proteomic technologies. More importantly, even when they are observed by global proteomic technologies, the information about the changes in protein levels and modifications that are specific to the membrane can be overshadowed. We propose to develop microfluidic technologies that will allow the study of sub-proteomes based on cellular compartments with an initial focus on plasma membrane proteins. Our short term objectives (1-3 years) are to develop new membrane solubilization protocols and an ensemble of microfluidic technologies for processing, identifying and relative quantitating membrane proteomes by mass spectrometry. An important aspect of our objectives is to provide training for students, postdoctoral fellows, and visiting scientists on the development of microfluidic proteomic technologies and mass spectrometry. Our medium term objectives (3-5 years) are to integrate these technologies into single devices to demonstrate their compatibility for analyzing sub-proteomes. Our long term objective is to apply these microfluidic technologies to study the dynamicity of the membrane proteome, to automate these systems, and to explore their commercialization.